Page last updated: 2024-08-24

xanomeline and pirenzepine

xanomeline has been researched along with pirenzepine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonifazi, A; Del Bello, F; Farande, A; Ferré, S; Matucci, R; Nesi, M; Petrelli, R; Piergentili, A; Quaglia, W; Vistoli, G; Yano, H1
Christopoulos, A; El-Fakahany, EE; Parsons, AM1
Christopoulos, A; El-Fakahany, EE; Lew, MJ; Parsons, AM1
Dai, J; Li, Z; Meltzer, HY; Roseman, AS; Snigdha, S1
Dehnicke, C; Deisz, RA; Gigout, S; Horn, P; Lehmann, TN; Wierschke, S1

Other Studies

6 other study(ies) available for xanomeline and pirenzepine

ArticleYear
Synthesis and biological evaluation of a novel series of heterobivalent muscarinic ligands based on xanomeline and 1-[3-(4-butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).
    Journal of medicinal chemistry, 2014, Nov-13, Volume: 57, Issue:21

    Topics: Animals; CHO Cells; Cricetulus; Molecular Docking Simulation; Muscarinic Agonists; Piperidines; Pyridines; Quinolones; Receptor, Muscarinic M1; Structure-Activity Relationship; Thiadiazoles

2014
Advances in CNS Drugs. Recent advances and considerations in the treatment of schizophrenia.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:7

    Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Clozapine; Double-Blind Method; Drug Costs; Drugs, Investigational; Humans; Olanzapine; Pirenzepine; Placebos; Pyridines; Randomized Controlled Trials as Topic; Schizophrenia; Thiadiazoles

1996
Pharmacological analysis of the novel mode of interaction between xanomeline and the M1 muscarinic acetylcholine receptor.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:3

    Topics: Animals; Atropine; Binding, Competitive; Carbachol; CHO Cells; Citrulline; Cricetinae; Humans; Kinetics; Muscarinic Agonists; N-Methylscopolamine; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Pirenzepine; Pyridines; Radioligand Assay; Receptor, Muscarinic M1; Receptors, Muscarinic; Recombinant Proteins; Thiadiazoles; Transfection; Tritium

1999
The assessment of antagonist potency under conditions of transient response kinetics.
    European journal of pharmacology, 1999, Oct-15, Volume: 382, Issue:3

    Topics: Animals; Artifacts; Atropine; Binding, Competitive; Calcium; Carbachol; CHO Cells; Cricetinae; Drug Antagonism; Humans; Intracellular Fluid; Kinetics; Models, Biological; Monte Carlo Method; Muscarinic Agonists; Muscarinic Antagonists; Pirenzepine; Pyridines; Radioligand Assay; Receptor, Muscarinic M1; Receptors, Muscarinic; Thiadiazoles; Time Factors

1999
Effect of muscarinic receptor agonists xanomeline and sabcomeline on acetylcholine and dopamine efflux in the rat brain; comparison with effects of 4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one (AC260584) and N-desmethylclozapine
    European journal of pharmacology, 2008, Oct-31, Volume: 596, Issue:1-3

    Topics: Acetylcholine; Animals; Antipsychotic Agents; Benzoxazines; Brain; Clozapine; Dopamine; Drug Synergism; Imines; Male; Nucleus Accumbens; Pirenzepine; Prefrontal Cortex; Pyridines; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Risperidone; Thiadiazoles

2008
Muscarinic acetylcholine receptor-mediated effects in slices from human epileptogenic cortex.
    Neuroscience, 2012, Oct-25, Volume: 223

    Topics: Action Potentials; Adult; Biophysics; Carbachol; Cerebral Cortex; Cholinergic Agonists; Drug Combinations; Electric Stimulation; Epilepsy; Excitatory Postsynaptic Potentials; Female; Humans; In Vitro Techniques; Male; Muscarinic Antagonists; Patch-Clamp Techniques; Pirenzepine; Pyridines; Receptors, Muscarinic; Thiadiazoles

2012